Clinical Trial Update: GIP and GLP-1 in Type 1 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating the use of GIP and GLP-1 in individuals with Type 1 diabetes to address hypoglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• GIP (glucose-dependent insulinotropic polypeptide)
• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Mikkel Christensen | Conditions: Hypoglycemia | NA | Status: COMPLETED